Is Kenvue Inc. (KVUE) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 24.6% / 30% | 3.0% / 30% | 8.0% / 30% | 0.34% / 5% | ✓ HALAL |
| DJIM | 24.6% / 33% | 3.0% / 33% | 8.0% / 33% | 0.34% / 5% | ✓ HALAL |
| MSCI | 32.0% / 33% | 3.9% / 33% | 10.4% / 33% | 0.34% / 5% | ✓ HALAL |
| S&P | 24.6% / 33% | 3.0% / 33% | 8.0% / 33% | 0.34% / 5% | ✓ HALAL |
| FTSE | 32.0% / 33% | 3.9% / 33% | 10.4% / 50% | 0.34% / 5% | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 58.4% | |
| Operating Margin | 17.8% | |
| Net Margin | 9.7% | |
| Return on Equity (ROE) | 14.4% | |
| Return on Assets (ROA) | 6.6% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $2.2B |
| Free Cash Flow | $1.7B |
| Total Debt | $8.7B |
| Debt-to-Equity | 80.6 |
| Current Ratio | 1.0 |
| Total Assets | $27.1B |
Price & Trading
| Last Close | $17.57 |
| 50-Day MA | $17.99 |
| 200-Day MA | $18.41 |
| Avg Volume | 41.9M |
| Beta | 0.5 |
|
52-Week Range
$14.02
| |
About Kenvue Inc. (KVUE)
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Purification Calculator
As a halal stock with 0.34% impermissible income, you need to purify your dividends.
Related Halal Stocks in Consumer Defensive
Frequently Asked Questions
Is Kenvue Inc. (KVUE) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Kenvue Inc. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Kenvue Inc.'s debt ratio?
Kenvue Inc.'s debt ratio is 24.6% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 32.0%.
Does Kenvue Inc. require dividend purification?
Yes, Kenvue Inc. has an impermissible income ratio of 0.34%, which means 0.34% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are Kenvue Inc.'s key financial metrics?
Kenvue Inc. has a market capitalization of $33.6B, trailing P/E ratio of 23.1, and revenue of $15.1B. The company maintains a gross margin of 58.4% and a net margin of 9.7%. Return on equity stands at 14.4%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.